Published in Clin Sci (Lond) on March 01, 1993
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
Trace metal, acute phase and metabolic response to endotoxin in metallothionein-null mice. Biochem J (1996) 1.04
Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis. Thorax (1996) 1.01
Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils. Antimicrob Agents Chemother (2000) 0.90
Peptidases from latex of Carica candamarcensis upregulate COX-2 and IL-1 mRNA transcripts against Salmonella enterica ser. Typhimurium-mediated inflammation. Mediators Inflamm (2014) 0.75
Tired of Lyme borreliosis. Lyme borreliosis in the Netherlands. Neth J Med (2011) 2.86
Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med (1990) 2.82
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology (2006) 2.47
Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol (2001) 1.95
Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA (1993) 1.88
Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS (2001) 1.81
Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med (1996) 1.70
Proinflammatory effects of IL-10 during human endotoxemia. J Immunol (2000) 1.69
Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism (1991) 1.68
Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax (2004) 1.63
Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun (1994) 1.57
The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer (1999) 1.53
Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J Infect Dis (1999) 1.51
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest (1994) 1.50
Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost (1996) 1.47
Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol (1995) 1.46
Towards implementation of optimum nutrition and better clinical nutrition support. Clin Nutr (2001) 1.45
Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD. Eur Respir J (2008) 1.43
Infusion of long-chain or medium-chain triglycerides inhibits peripheral glucose metabolism in men. JPEN J Parenter Enteral Nutr (1995) 1.42
[Increased frequency of icterus in parenterally fed patients after a change of lipid emulsion]. Ned Tijdschr Geneeskd (1999) 1.40
The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab (1991) 1.37
Use of sodium hydroxide solution to clear partially occluded vascular access ports. JPEN J Parenter Enteral Nutr (1993) 1.37
The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis (2011) 1.33
Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock (1995) 1.32
Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol (1991) 1.29
The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol (2007) 1.29
Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol (1997) 1.28
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun (1999) 1.26
Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia. Kidney Int (2001) 1.26
Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J Immunol (1997) 1.21
Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab (1990) 1.19
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood (2000) 1.18
Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am J Respir Crit Care Med (1998) 1.17
The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest (1997) 1.17
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia. Diabetologia (2011) 1.17
TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol (2001) 1.16
IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol (2001) 1.14
New insights into pathways that determine the link between infection and thrombosis. Neth J Med (2012) 1.13
Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes. Clin Immunol Immunopathol (1984) 1.13
Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J Infect Dis (2000) 1.12
Disseminated intravascular coagulation. Thromb Haemost (1999) 1.12
Lyme borreliosis vaccination: the facts, the challenge, the future. Trends Parasitol (2010) 1.12
Experimental pneumococcal meningitis in mice: a model of intranasal infection. J Infect Dis (2001) 1.11
Rage signalling promotes intestinal tumourigenesis. Oncogene (2012) 1.11
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo. J Immunol (2001) 1.10
The quantification of gluconeogenesis in healthy men by (2)H2O and [2-(13)C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-(13)C]glycerol. J Clin Endocrinol Metab (2001) 1.10
Endothelial barrier dysfunction in septic shock. J Intern Med (2015) 1.09
Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck (1997) 1.08
Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J (2004) 1.08
Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr (2001) 1.07
Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood (1997) 1.06
Increased basal glucose production in type 1 Gaucher's disease. J Clin Endocrinol Metab (1995) 1.05
The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis. Infect Immun (2000) 1.05
Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun (1996) 1.04
Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur Respir J (2006) 1.04
Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med (2008) 1.02
Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J Immunol (2001) 1.02
Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis (1994) 1.01
Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS (1993) 1.00
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy. J Acquir Immune Defic Syndr (2001) 1.00
Endotoxin and the release of tumor necrosis factor receptors. Prog Clin Biol Res (1994) 1.00
Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis (1998) 1.00
The sick sinus syndrome. Acta Med Scand (1976) 1.00
Preferential protection of Borrelia burgdorferi sensu stricto by a Salp15 homologue in Ixodes ricinus saliva. J Infect Dis (2008) 1.00
Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial. Diabetologia (2011) 1.00
Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost (2006) 1.00
Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia. J Immunol (2001) 0.99
Mice without phosphatidylcholine transfer protein have no defects in the secretion of phosphatidylcholine into bile or into lung airspaces. Proc Natl Acad Sci U S A (1999) 0.99
CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection. J Infect Dis (2001) 0.99
Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis (1999) 0.99
Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia. Eur Respir J (2008) 0.98
Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood (1997) 0.98
Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in man. J Pharmacol Exp Ther (1984) 0.97
Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood. Antimicrob Agents Chemother (1998) 0.97
Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation. Eur Respir J (2007) 0.97
Recent insights into the pathogenesis of bacterial sepsis. Neth J Med (2010) 0.96
White adipose tissue: getting nervous. J Neuroendocrinol (2003) 0.96
Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism (1990) 0.96
HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy. Lancet (2003) 0.96
Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsis. J Infect Dis (2000) 0.95
Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies. Semin Thromb Hemost (2001) 0.95
Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol (1993) 0.95
Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease. Am J Med (1997) 0.94
The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis. Kidney Int (2006) 0.94
Biologic responses to IFN-alpha administration in humans. J Interferon Cytokine Res (2000) 0.93
Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia. Thromb Haemost (1997) 0.93
Protein C in pneumonia. Thorax (2005) 0.93
The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury. J Thromb Haemost (2005) 0.93
The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha receptors during human endotoxemia. Blood (1999) 0.93
A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans. Antimicrob Agents Chemother (2000) 0.92
Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis. J Thromb Haemost (2007) 0.92
Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med (2001) 0.92
Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab (2007) 0.92
Review article: Regulation of glucose production with special attention to nonclassical regulatory mechanisms: a review. Metabolism (2001) 0.91
Novel approaches to the management of disseminated intravascular coagulation. Crit Care Med (2000) 0.91